METTL16 and intestinal cancer: While most cancer-associated mutants (R200Q, E408K, P460L, T549A, and R552H) did not alter the activity of METTL16, other cancer-associated mutants (G110C identified in an intestinal cancer patient and R241Dfs*2 identified in a colorectal cancer patient) nearly or completely abolished methylation activity.